Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 967 | 1001 | 1180 | 759 | 1473 | 2478 |
Fund Return | -3.29% | 0.06% | 18.05% | -8.8% | 8.05% | 9.5% |
Place in category | 520 | 490 | 524 | 467 | 375 | 236 |
% in Category | 99 | 88 | 99 | 91 | 83 | 61 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Eventide Healthcare & Life ScienceI | 1.17B | -2.57 | -6.72 | 9.79 | ||
Eventide Gilead N | 393.72M | -3.46 | -8.98 | 9.28 | ||
Eventide Gilead A | 316.46M | -3.51 | -9.02 | 9.23 | ||
Eventide Gilead C | 156.74M | -4.12 | -9.71 | 8.40 | ||
Eventide Healthcare & Life ScienceA | 119.06M | -2.81 | -6.95 | 9.51 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 14.6B | 18.77 | 5.53 | 12.65 | ||
T. Rowe Price Mid-Cap Growth I | 13.38B | 7.79 | 0.27 | - | ||
T. Rowe Price Mid-Cap Growth | 12.45B | 7.68 | 0.14 | 10.48 | ||
Vanguard Mid-Cap Growth Index Admir | 12.09B | 11.75 | -0.99 | 10.25 | ||
T. Rowe Price New Horizons I | 10.75B | 3.91 | -9.99 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Trane Technologies | IE00BK9ZQ967 | 6.02 | 406.51 | -0.88% | |
Waste Connections | CA94106B1013 | 4.20 | 183.37 | -0.20% | |
TransMedics | US89377M1099 | 4.03 | 82.70 | -6.41% | |
Datadog | US23804L1035 | 3.69 | 125.25 | -4.70% | |
The Trade Desk | US88339J1051 | 3.56 | 118.63 | -5.76% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review